Your question is above my pay grade unfortunately but remember...

Your question is above my pay grade unfortunately but remember Glenn Poswell and his network accumulated 50 million shares without anyone noticing.

The better question in my mind is why shareholders panic. This company has consistently delivered for years and the clinical trials are tackling some of the most significant unmet needs in the sector, including and importantly ARDS.

If this new group is buying already then it’s been very covert and the feedback I received was exceptional. Their last deal was a Disallowed and they have a huge amount of horsepower apparently.